Featured News

Urano Lab receives funding to test the efficacy of a Sigma 1 receptor agonist pridopidine

Dr. Urano

The Snow Foundation, the Ellie White Foundation, and the Unravel Wolfram Syndrome have donated funds to the research lab of Fumihiko Urano, MD, PhD.

The research team will use the funds to test the efficacy of a Sigma 1 receptor agonist, pridopidine, developed by Prilenia in pre-clinical models of Wolfram syndrome. Successful completion of this study may lead to a future clinical trial of pridopidine in patients with Wolfram syndrome.

To learn more about Wolfram syndrome and Urano Lab, visit here.